IMMU Financial Facts
Product sales: 597.51KResearch and development: 129.19K
See Full Income Statement
Accumulated other comprehensive income: -127.73K
Total current liabilities: 14.33M
See Full Balance Sheet
Immunomedics (IMMU) Earnings
|
Expand Research on IMMU
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -44.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/20  |
 |
Q220 | N/A | -$0.34 | N/A | N/A | $14.53M | N/A | N/A | N/A | |
| 5/6/20 | |
Q120 | -$0.44 | -$0.45 | +$0.01 | N/A | $2.36M | N/A |  | | Details |
| 2/27/20 | |
Q419 | -$0.50 | -$0.46 | -$0.04 | $295K | $530K | N/A | | | Details |
| 10/30/19 | |
Q319 | -$0.49 | -$0.40 | -$0.09 | N/A | $400K | N/A | | | Details |
| 2/25/19 | Q219 | -$0.84 | -$0.34 | -$0.50 | N/A | $50K | N/A | | | Details | |
| 11/7/18 | |
Q119 | -$0.34 | N/A | N/A | N/A | $1.86M | N/A | | | Details |
| 8/23/18 | |
Q418 | -$0.68 | -$0.22 | -$0.46 | $400K | $4.27M | N/A | | | Details |
| 5/9/18 | |
Q318 | -$0.21 | -$0.15 | -$0.06 | $500M | $1.3M | = | | | Details |
